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Our research describes the provision of palliative care services at a time of transition. 
Typically, palliative care has offered a holistic, non-curative focus with an emphasis on 
improving the quality of life of people with life-limiting conditions. Traditionally it has aimed 
to improve the conditions of people who were dying of cancer. Palliative care now seeks to 
extend a holistic, team-based and family-centred approach to people with other life-limiting 
conditions. Until now the degree to which this aim was reflected in the actual provision of 
health services has been unclear. There has been a paucity of population-based data on which 
to base equitable healthcare decision-making regarding the extension of palliative care to 
people suffering from a range of life-limiting, complex and painful conditions. Our study 
provides such data for Western Australia and provides an insight into who is missing out on 
palliative care services in the last year of life.  
The study was a longitudinal, population-based, retrospective cohort study of 26,882 people 
who died in Western Australia between 1 July 2000 and 31 December 2002. A secondary 
analysis was conducted of data from the Silver Chain Nursing Association and two 
administrative health databases of the Western Australian Data Linkage System: the Mortality 
Register and the Hospital Morbidity Data System. 
Three possible palliative care constituencies (that is, groups of people who would benefit from 
palliative care) were proposed in order to model three scenarios of service provision: 
(a) a minimal constituency.  That is, a disease-based potential palliative care constituency 
composed of people who died of any of the following 10 conditions: cancer, heart 
failure, chronic obstructive pulmonary disease, renal failure, Alzheimer's disease, liver 
failure, Parkinson’s disease, motor neurone disease, HIV/AIDS, and Huntington’s 
disease;  
(b) a mid-range constituency. That is, a condition-based potential palliative care 
constituency composed of people who were hospitalised in the last 12 months of their 
lives for a condition listed as an underlying cause of death on their death certificate; and  
(c) a maximal constituency. That is, a condition-based potential palliative care constituency 
composed of people who died from all causes except those that produced sudden deaths, 
defined as poisoning, injury, or originating during pregnancy or the puerperium.  
Key Findings1 
The minimal constituency represented 50% of all deaths during the 2.5-year study period, 54% 
of which were attributed on the death certificate to cancer. Four out of five of people in the 
minimal constituency were aged over 65 years; one in 50 was Aboriginal; half were married 
and a third were widowed; seven out of 10 lived in a major city; and a third were 
socioeconomically disadvantaged.   
About half of the people in the minimal constituency died in hospital, about a third in their 
usual place of residence, the remainder in a residential aged care facility or elsewhere. Use of 
specialist palliative care services reduced the likelihood of dying in hospital or in a residential 
aged care facility. 
                                                 
1 Only results from the minimal constituency are reported in the Executive Summary. 
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The rate of use of specialist palliative care services by people dying of malignancies (68%) 
was much higher than the rate for people dying of non-malignant conditions (8%). In addition, 
people were less likely to receive specialist palliative care services if they were aged 84 years 
or over; female; Aboriginal; living in a remote area; or socioeconomically disadvantaged. 
In the last 12 months of life, one person in four in the minimal constituency had a hospital 
admission for specialist palliative care services, whereas nine people out of 10 had a hospital 
admission not involving specialist palliative care services. Our findings suggest that the use of 
specialist palliative care services potentially reduces the demand on other hospital beds. 
Slightly less than one person in three received home-based specialist palliative care services in 
the last 12 months of life. People who received home-based specialist palliative care services 
were more likely to receive home-based non-palliative services. People who received home-
based non-palliative care services, and did not receive home-based specialist palliative care 
services, had more visits and more home hours of home-based non-palliative care services than 
people who received home-based specialist palliative care services and home-based non-
palliative care services.  
People who received specialist palliative care services at home and/or in hospital spent more 
time in hospital than people who did not receive any specialist palliative care services. 
However, people who received only home-based specialist palliative care services spent less 
time in hospital than people who did not receive any specialist palliative care services. Referral 
to home-based palliative care therefore potentially ensures the best possible, and most 
appropriate use, of the various kinds of home-based services. 
The annual cost of providing hospital-based specialist palliative care services in Western 
Australia for the study period was calculated at $9.2M. If one half of all people in the minimal 
constituency had received hospital-based specialist palliative care services, this cost would 
have been doubled to $18M. Providing home-based specialist palliative care services to one 
half of this constituency would cost $9.1M, based on current home-based costs.  
Conclusions 
Our study identified those people who are the most disadvantaged in respect to receiving 
specialist palliative care services. A significant proportion of people within one of our 
potential palliative care constituencies, and who died in the period July 2000 to December 
2002, did not receive specialist palliative care. These people may have received other forms of 
health care. They may also have benefited from the holistic, family-oriented services provided 
by generalist palliative care services. Not surprisingly, and given the traditional palliative care 
focus on cancer, those people dying of cancer were well serviced in comparison to people 
dying from other complex and painful conditions. Nevertheless one third of the people who 
died of cancer did not receive specialist palliative care.  
Other measures of disadvantage have been noted that are reflective of broader disadvantage 
within Australian health care. To be Aboriginal, elderly, living in a rural or remote area and to 
be socially disadvantaged lessens one's chance of receiving appropriate, and apparently cost 
effective, services in the last weeks and months of life. By pointing to the areas of most critical 
need, this study assists policy and planning in the provision of health services. 
Our study focuses on people who are not receiving specialist palliative care services, while 
also providing a unique window into Western Australian palliative care services. Once clients 
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have been referred to palliative care, they are provided with a cohesive service by the network 
of local providers. Those who receive specialist palliative care services in hospital are more 
likely to receive home-based palliative care and the reverse is also true. This group of people 
are also more likely to die in their own homes, a common request of dying people that has been 
reported in the literature and anecdotally by health care providers. 
By providing a comprehensive and empirically grounded picture of services used in the last 
year of life, this study has sought to develop and test a universally accepted normative 
benchmark for defining palliative care needs at population level. It makes a strong case for 
improving the range and level of palliative care provided to terminally ill people. Extending 
palliative care to accommodate even a minimal constituency is a costly exercise. Findings from 
our study allow informed advocacy to occur on behalf of vulnerable populations in a country 






Executive summary.............................................................................................................................. iv 
Key Findings .......................................................................................................... iv 
Conclusions..............................................................................................................v 
Section 1 Objectives .......................................................................................................................1 
Section 2 Background.....................................................................................................................2 
Palliative care constituencies: Who should receive palliative care? ......................2 
Socio-demographic characteristics of people in the palliative care constituencies
..................................................................................................................................3 
Place of death ...........................................................................................................3 
Palliative care patterns of delivery ..........................................................................4 
Home- and hospital-based palliative care services .................................................4 
Costs of palliative care.............................................................................................5 
Section 3 Methods ..........................................................................................................................6 
Formative study .......................................................................................................6 
Longitudinal, population-based, retrospective cohort study ..................................6 
Design................................................................................................................6 
Data sources ......................................................................................................6 
Outcome variables.............................................................................................7 
Section 4 Results...........................................................................................................................10 
Defining a model of palliative care constituencies of potential need...................10 
Perspectives from the formative study ...........................................................10 
Defining a conceptual model of palliative care constituencies......................11 
Describing the Western Australian palliative care constituencies .......................13 
The sizes of the three constituencies ..............................................................13 
Proportions of the population with each condition in the minimal 
constituency.....................................................................................................14 
Demographic characteristics of people in the three palliative care 
constituencies ..................................................................................................15 
Palliative care and place of death ..........................................................................17 
Place of death for people in the palliative care constituencies ......................17 
Effects of receiving palliative care on place of death ....................................18 
Specialist palliative care delivery patterns for population subgroups ..................19 
Current levels of use of specialist palliative care services.............................19 
Levels of use of specialist palliative care services for people with and 
without malignancies ......................................................................................20 
Levels of use of specialist palliative care services for socio-demographic 
groups ..............................................................................................................20 
Home- and hospital-based specialist palliative care .............................................25 
Hospital-based specialist palliative care services...........................................25 
Home-based specialist palliative care services ..............................................26 
Specialist palliative care services and hospitalisations ..................................27 
A projected costing model for specialist palliative care .......................................28 
Costing model for hospital-based specialist palliative care services.............28 
Costing model for home-based specialist palliative care services.................29 
Costing model for both hospital- and home-based specialist palliative care 
services ............................................................................................................30 
Section 5 Limitations....................................................................................................................32 
Section 6 Conclusions and implications ......................................................................................33 
Section 7 Recommendations ........................................................................................................34 
Recommendations for practice ..............................................................................34 





Who receives specialist palliative care in Western Australia –– and who misses out     1 
Section 1 Objectives 
The objectives of the research were as follows: 
1. To define who would benefit from receiving palliative care, that is, to define a model of 
palliative care constituencies. 
2. To describe the characteristics of the people in Western Australian in the palliative care 
constituencies in terms of their condition, age group, gender, aboriginality, geographical 
remoteness and socioeconomic disadvantage. 
3. To determine where people in the Western Australian palliative care constituencies die, 
and the effects of receiving palliative care during the last 12 months of life on their place 
of death.  
4. To study patterns of delivery of specialist palliative care services during the last 12 
months of life, comparing use between different socio-demographic groups and causes of 
death.  
5. To study the relationships between home-based and hospital specialist palliative care 
services for people during the last 12 months of life.  
6. To develop a model to estimate the cost of an increased demand on specialist palliative 
care services. 
 
Section 1 Objectives 
Background 
 Who receives specialist palliative care in Western Australia –– and who misses out 2 
Section 2 Background 
 
Palliative care aims to improve the quality of life of people with life-limiting conditions by the 
emphasis on relief from pain and symptoms; by the involvement of their family and friends; 
and by the adoption of a holistic, non-curative focus. Historically, hospice and palliative care 
have focused on people with cancer, but have, more recently, extended to people with other 
conditions, such as neurodegenerative diseases, respiratory diseases, end stage organ failure 
and HIV/AIDS.  
While a palliative care approach should be a vital and integral part of all clinical practice, 
whatever the illness or stage, specialist palliative care offers specific end-of-life services that 
are informed by knowledge and practice of palliative care principles and are supported by 
specialist palliative care services (SPCS). Such care is provided through a network of 
domiciliary care, day-care, hospital support and hospital- or hospice-based in-patient services.  
In Australia there is limited evidence about the numbers of people who require access to SPCS. 
To address this need the following report provides a population-based study designed to 
estimate the proportion of people who are receiving SPCS and who should be receiving it 
during the last 12 months of life. 
Palliative care constituencies: Who should receive palliative care? 
Specialist palliative care has traditionally been provided to people with malignant conditions, 
and even now, the vast majority of people who receive SPCS have been diagnosed with 
cancer1. However, it is now widely acknowledged that the needs of many people dying of non-
malignant conditions are as great as the needs of those with malignant conditions. The holistic 
and family-based focus provided through SPCS could benefit these people2-4.  
People with non-malignant conditions receive less SPCS than people with malignant 
conditions for various reasons including patterns of referral5-6; problems in estimating 
prognosis, especially end of life7-8; concerns of medical practitioners and other healthcare 
workers about their lack of palliative care skills9-11; and the differences in the needs of people 
with non-malignant conditions8,12. 
Few studies define the extent of need for SPCS among the general population. One such study, 
conducted in South Australia13, estimated that 70% of people with life-limiting illnesses would 
benefit from SPCS. Another study of the general population, conducted in the United 
Kingdom3, compared the needs of people with malignant and non-malignant conditions by 
surveying their families. The researchers determined the average level of need in people with 
malignancies (in terms of number of symptoms, number of distressing symptoms, and number 
of symptoms lasting for more than six months). They investigated the same variables in people 
with non-malignant conditions and found that 17% of people who died from non-malignant 
conditions had needs that were at least as great as the average level of need in people with 
malignancies in terms of these three criteria. They estimated that providing SPCS for these 
people would represent a 79% increase in the need for SPCS. They add, however, that this is 
only a conservative estimate of need because it selects people with non-malignant conditions 
with a level of severity comparable to that of the one third of people with the most advanced 
malignant conditions. 
Section 2 Background 
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The calls to extend SPCS to non-malignant populations and the paucity of research in this area, 
led to the first objective in the present study. This first objective was to define who would 
benefit from receiving palliative care, that is, to define a model of palliative care 
constituencies. 
Socio-demographic characteristics of people in the palliative care 
constituencies 
Palliative Care Australia has stated in its strategic plan of 2003-2006 that its vision is to 
provide the 'world’s best palliative care for ALL Australians'. To accomplish this vision, its 
first strategic aim is to 'improve equity and access to palliative care across Australia', partly by 
means of 'identify[ing] gaps and inequities in service provision and research and advocat[ing] 
for solutions'. The present study helps to address this aim by providing population data about 
the socio-demographic characteristics of people requiring palliative care in Western Australia. 
Defining and describing the palliative care constituency in Western Australia is useful for 
healthcare planning from several points of view: 
1. It provides data about the numbers of people who may require SPCS, thus facilitating 
planning of the extent of the services. 
2. It provides data about the characteristics of people who may require SPCS, thus 
facilitating planning of the nature and distribution of services in terms of: 
• conditions requiring services; 
• ages and gender distribution of people requiring services; 
• proportions of Aboriginal people requiring services; 
• geographical distribution of people requiring services; and 
• socioeconomic levels of people requiring services. 
The second objective of the present study, therefore, was to describe the characteristics of the 
people in Western Australia in the palliative care constituencies in terms of their condition, age 
group, gender, aboriginality, geographical remoteness and socioeconomic disadvantage. 
Place of death 
One of the goals of SPCS is to enable people to die in the way that they wish. Most people, 
when asked where they wish to die, express a wish to die at home14-16. Place of death, however, 
is correlated with a variety of factors outside the patient’s control, including the condition 
causing death17,18; the patient’s age17,19-24; socioeconomic level23,25-26; level of family 
support15,20,22; gender17,20-21,24; whether the patient is single20-21; and the period of time between 
diagnosis and death24. SPCS can also influence place of death. In general, people who receive 
SPCS are more likely to die at home27-29 and also more likely to die where they wish15.  
The third objective of the present study, therefore, was to determine where people in the 
Western Australian palliative care constituencies die, and the effects of receiving palliative 
care during the last 12 months of life on their place of death. 
Background 
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Palliative care patterns of delivery 
Previous studies show that people with cancer access SPCS more than people with other 
conditions. One study of four palliative care services in London reported that 95% of the 
patients had been diagnosed with cancer1. A South Australian survey of bereaved families and 
friends in the general population reported that palliative care services had been accessed in 
61% of cases when the decedent had had cancer, but in only 36% when the decedent did not 
have cancer13. A population-based, South Australian study confirmed that most people who die 
of cancer (68% in 1999) receive SPCS30.  
The socio-demographic characteristics of people receiving SPCS are less well known. A South 
Australian, population-based study determined the socio-demographic characteristics of people 
with cancer who received SPCS30. In this study, people were less likely to receive services if 
they were 80 years and over; came from a rural area; and had three months or less between 
diagnosis and death. Gender, socioeconomic status and race, however, did not predict whether 
a person received SPCS. Other research also shows that people over 80 years are less likely to 
receive SPCS 31. This information is restricted to people with cancer. Until now there has been 
no similar Australian population-based data on people who die of other conditions.  
Objective four of the present study was to study patterns of SPCS delivery during the last 12 
months of life comparing use between different socio-demographic groups and conditions 
causing death 
Home- and hospital-based palliative care services 
People with life-limiting conditions and their families usually prefer the patient to remain at 
home for as much of the time as possible and to die at home if that can be achieved in comfort 
and security14-16,32-33. Home-based SPCS, therefore, have been established to meet patients’ and 
families’ needs as much as possible in the home environment. Early work in this area found 
that patient pain and carer anxiety were increased when care was provided in the home34. 
However, pain control in SPCS, both at home and in hospices, has improved greatly over the 
past few years and is now very effective35.  
Hospital admissions occur during the closing stages of life for several reasons. One reason is 
the deterioration of the patient’s health to a point where it cannot be adequately treated at 
home36,37. Another factor that leads to hospital admissions is the inability of carers to maintain 
an adequate level of care owing to the physical, psychological and/or financial stress of 
caregiving over an extended time period37,38. A third factor is insufficient coordination of or 
support by healthcare services to maintain home care36,37.  
Hospital admissions frequently occur for reasons unrelated to the condition causing death. In a 
study of 41 deaths in a retirement community occurring over an 18-month period, 46% of 
people had been admitted to hospital in the last year of life, and these hospital admissions were 
for acute conditions, such a pneumonia (52%), and accidental injuries (15%) as well as for 
endstage chronic diseases (33%)39.  
Few studies report the numbers of people in the population who receive home-based SPCS, 
hospital-based SPCS or a combination of the two. The present study reports these figures for 
Background 
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the Western Australian population. Objective five was to study the relationships between 
home-based and hospital SPCS for people during the last 12 months of life.  
Costs of palliative care 
End-of-life care is costly. In one study, the cost of caring for old people in their last year of life 
was 276% higher than the cost of caring for age-matched old people who were not in their last 
year40.  
Australia is faced with the challenge of a finite specialist palliative care budget and mounting 
pressure to expend these services to all people dying from advanced incurable diseases. This 
challenge is amplified by the lack of reliable and representative data about the needs of dying 
people. This information is crucial, especially in the context of current health funding. In 
Western Australia, palliative care receives about 0.5% of the $2.6 billion allocated by the State 
Government to health. Palliative care professionals have raised concern about this situation41, 
suggesting: (a) that patients are missing out on specialised pain relief and psychological 
support; (b) that directing money into intensive care beds as opposed to palliative care beds is a 
poor use of resources; and (c) that the non-promotion of palliative care services is due to their 
scarceness. The Director General of the Western Australian Health Department has said that 
more research and planning are needed to determine future demand for palliative care services. 
This includes investigating who is missing out and why this is the case41. 
Specialist palliative care services may reduce costs. Recently, Marie Curie Cancer Care in the 
United Kingdom stated that that £100M in hospital beds could be saved each year by providing 
home care for 37,000 patients42. There is evidence that specialist palliative care services, 
particularly when delivered at home, reduce costs43-46, though this may vary, for instance when 
the period of service provision is extended43,47. However, randomized controlled trials 
comparing different specialist palliative care services with one another and with conventional 
care are fraught with methodological difficulties37,48-49, and further well-controlled studies are 
still needed in this area50. 
At the same time, information concerning the current costs of specialist palliative care 
provision, as well as the projected costs of providing these services to people with non-
malignant conditions, is essential for policy and planning. The present study provided an 
opportunity to obtain such data. Objective six, therefore, was to develop a model to estimate 
the cost of an increased demand on SPCS. 
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Section 3 Methods 
 
Two studies were conducted: A formative study was conducted to obtain the perspectives of 
palliative care stakeholders and a population-based, retrospective cohort study was conducted 
to obtain a description of the people in Western Australia who are currently receiving specialist 
palliative care services (SPCS) and the people who would be likely to benefit from SPCS. The 
results of the formative study informed Objective one. The results of the population-based 
study informed Objectives two to six. 
Formative study 
Written invitations to participate in the study were sent to facilities that provided palliative 
care and care for aged people, special interest groups and individuals known to be working in 
the area in Western Australia. Participants included volunteer carers, as well as staff from 
palliative care sites, acute care hospitals with palliative care units, domiciliary nursing services 
and aged care facilities. Both private and public hospitals, and both city and rural settings, 
were represented. Professionals included social workers, nurses, medical practitioners, 
occupational therapists and physiotherapists. Six focus groups, composed of 38 participants, 
were conducted. Four other participants, who were unable to attend the focus groups, were 
interviewed individually. 
The groups were facilitated by the first two principal investigators. Four guiding questions 
were used with the focus groups: (a) What is palliative care? (b) Who should receive palliative 
care? (c) At what point in the illness history should palliative care be offered? and (d) What 
diagnostic categories of illness should receive palliative care? Focus groups were conducted 
around these four questions until saturation (repetition of the same themes by different 
participants with no new themes) occurred51.  
Common themes were generated from the discussion in the focus groups and the interviews.  
Longitudinal, population-based, retrospective cohort study 
Design 
The main study was a longitudinal, population-based, retrospective cohort study of the people 
who died in Western Australia from 1 July 2000 to 31 December 2002. The cohort was defined 
over a 2.5-year period to coincide with ICD-10-AM codes52.  
Data sources 
This study relied on the secondary analysis of data from the Silver Chain Nursing Association 
and two administrative health databases of the Western Australian Data Linkage System 
(WADLS): the Mortality Register and the Hospital Morbidity Data System.   
The Western Australian Record Linkage system (shown in Figure 1) links together data from 
over a period of 20 years, and from a variety of administrative data sets, and relates these to 
individual people53. The system consists of six core datasets: birth records, midwives’ 
notifications, cancer registrations, inpatient hospital morbidity data, inpatient and public 
outpatient mental health services data and death records. Residential and community care data 
Section 3   Methods 
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sets, as well as pharmaceutical and medical benefits records, are being added to the system as 
they become available53. The WA Record Linkage Project has been validated for a similar 
study that focused on patterns of care and the outcomes of health services for end-stage renal 
disease54. There are three main advantages of using data from the record linkage project. First, 
it is more cost-effective than studies that rely on primary data collection and data entry. 
Second, it avoids problems that result when individuals are lost to follow-up or do not respond. 
Last, the privacy of the medical records is fully protected, because probabilistic matching 
techniques are used for the linkages between health data sets54. 
The Silver Chain Nursing Association database provided information regarding home-based 
SPCS during the last 12 months of life. Silver Chain provides over 90% of the home-based 
SPCS in Western Australia.  
The Mortality Register contained information from death certificates. The death certificate is 
completed by a doctor or coroner and describes the cause of death. It consists of two parts. Part 
1 of the Death Certificate lists the sequence of diseases or conditions that led directly to death 
(the ‘morbid train of events’). The last recorded cause in Part 1 of the Death Certificate is 
called the ‘Underlying Cause of Death’. Part 2 of the Death Certificate records other diseases 
or conditions that contributed to the death but were not directly attributable to the morbid train 
of events that led to death. This study used data from Part 1 only of the Death Certificate.   
The Hospital Morbidity Data System provided information regarding hospital-based SPCS 
during the last 12 months of life. Specialist palliative care admissions were identified from the 
Type of Episode of Care data item.   
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Outcome variables 
The outcome variables in this study were as follows: 
1. Cause of death 
2. Place of death 
3. Use of SPCS in the last 12 months of life 
4. Demographic variables 
For the purposes of analysis, cause of death was coded as malignant (ICD 10 codes: C00 – 
D48) or non-malignant. Nine non-malignant causes of death were given particular attention. 
These were:  
• heart failure (ICD 10 codes: I500, I501, I509, I111, I130, I132);  
• renal failure (ICD10 codes: N180, N188, N189, N102, N112, N132, N120, N131, N132; 
but excluding acute renal failure: ICD10 code N17);  
• chronic obstructive pulmonary disease (ICD10 codes: J40, J410, J411, J418, J42, J430, 
J431, J432, J438, J439, J440, J441, J448, J449);  
• Alzheimer's disease (ICD10 codes: G300, G301, G308, G309); 
• liver failure (ICD10 codes: K704, K711, K721, K729);  
• Parkinson’s disease (ICD10 code: G20);  
• Motor Neurone Disease (ICD10 code: G122);  
• HIV/AIDS (ICD10 codes: B20 – B24); and 
• Huntington’s disease (ICD10 code: G10).  
Place of death was coded in terms of location and accommodation setting. Location was coded 
as the usual place of residence or elsewhere. Accommodation setting was coded as hospital, 
hospice, aged-care facility or other. ‘Other’ accommodation included private residences 
(owned or private/public rental), independent living units within retirement villages, boarding 
houses, supported accommodation facilities other than residential aged care facilities, and 
temporary shelters. 
To determine whether receiving palliative care during the last 12 months of life affected where 
people died, multinomial logistic regression was used. This analysis was performed on the 
minimal constituency, which consisted of 11,752 people after excluding those who died in a 
hospice, were aged less than 35 years, or had missing SEIFA or ARIA values. Deaths in a 
hospice were excluded as an outcome variable because it is a specialist palliative care service 
and, therefore, could not be used as both an independent and dependent variable. People aged 
less than 35 years were excluded from the analysis because the validity of the multinomial 
logistic regression model was compromised by the age variable containing categories with no 
count data (i.e., no people aged less than 35 years died in a residential aged care facility). The 
analysis was adjusted for the following known confounders: age, gender, aboriginality, social 
disadvantage, geographic remoteness, place of residence prior to death, and cause of death 
(i.e., the 10 tracer conditions that defined the minimal estimate).  
Use of SPCS in the last 12 months of life was divided into hospital-based SPCS and home-
based SPCS. Individuals could be receiving both, one or neither. Hospital-based SPCS was 
described in terms of: (a) its presence or absence, (b) the number of admissions, and (c) the 
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length of stay for each admission. Home-based SPCS was described in terms of: (a) its 
presence or absence, (b) the number of visits and (c) in-home client attributable time (hours) 
for each visit. 
The demographic variables recorded in this study were as follows: 
• Age, derived from the Mortality Register, and grouped into 10-year age groups, with a  
1-14 years age group and an 85+ age group. 
• Gender, derived from the Mortality Register. 
• Aboriginality, derived from the Mortality Register and Hospital Morbidity Data System, 
coded as Aboriginal or not. 
• Geographical remoteness, derived from the Accessibility Remoteness Index of Australia 
(ARIA+), and coded into six categories (major cities of Australia, inner regional 
Australia, outer regional Australia, remote Australia, very remote Australia, and 
migratory). 
• Socio-economic disadvantage, derived from the Index of Socio-Economic Disadvantage 
(IRSD) taken from the Socio-Economic Indices for Areas, based on the 2001 Census 
(SEIFA). This was divided into five categories (most disadvantaged [lowest 10%], more 
disadvantaged [next 15%], average [next 25%], less disadvantaged [next 25%], and least 
disadvantaged [top 25%]). 
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Section 4 Results 
Defining a model of palliative care constituencies of potential need 
Key points 
1. A conceptual model of palliative care constituencies (people likely to benefit from 
palliative care) was developed from the research literature and from focus groups 
and interviews with workers in the field. It consisted of minimal, mid-range and 
maximal constituencies. 
2. The minimal palliative care constituency included people who died of any of the 
following 10 tracer conditions: cancer, heart failure, renal failure, chronic 
obstructive pulmonary disease, Alzheimer’s disease, liver failure, Parkinson’s 
disease, motor neurone disease, HIV/AIDS and Huntington’s disease. 
3. The mid-range palliative care constituency included people who were hospitalised in 
the last 12 months of life for a condition that was later listed as an underlying cause 
of death on their death certificate. 
4. The maximal palliative care constituency included people who died from all causes 
except those that produced sudden deaths, defined as poisoning, injury, or 
originating during pregnancy or the puerperium. 
Objective one was to define who would benefit from receiving palliative care, that is, to define 
a model of palliative care constituencies. A formative study was conducted to obtain 
perspectives of palliative care workers on this question. The results of this study as well as a 
literature review were used to construct a model of palliative care constituencies. 
Perspectives from the formative study 
As described in the Methods, the participants in the formative study were asked four questions: 
(a) What is palliative care? (b) Who should receive palliative care? (c) At what point in the 
illness history should palliative care be offered? and (d) What diagnostic categories of illness 
should receive palliative care? 
With regard to the question of what palliative care is, there was a high level of agreement 
among participants in the focus groups and interviews on the essential components of palliative 
care. Common themes were: that palliative care is patient-centred; that it incorporates physical, 
psychological and spiritual nurturing; that it may be given alone or in conjunction with active 
treatment; that it is care that palliates; and that it is care that ensures quality of life until death. 
Notably, at this stage of the questioning, there was no suggestion that palliative care should be 
restricted to, or extended from, people dying of cancer. 
With regard to the second question, who should receive palliative care, some participants 
expressed concern that this definition of palliative care was idealistic and not often achieved, 
and that, in reality, the kinds of care offered to dying people depend upon:  
• funding models that allocate funding to medical care rather than people care;  
• historical patterns of service delivery that target only people with cancer;  
Section 4 Results 
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• the lack of appropriate knowledge and skills for dealing with non-malignant end-stage 
conditions among healthcare workers;  
• a lack of knowledge in the general population, leaving families of patients who might 
benefit from palliative care uninformed of the services that might benefit them;   
• lack of coordination of services and territorial tensions between designated palliative 
care services and non-designated services that also care for people with end-stage 
conditions; and  
• reluctance of doctors to refer their patients to palliative care because of the perception 
that doing so is an admission of failure.  
These findings suggested that the focus upon cancer in palliative care was principally a 
function of organisational and cultural restraints, rather than because people with cancer were 
considered to have a greater need than those with other kinds of conditions. 
When asked the third question, at what point in the illness history palliative care should be 
offered, participants agreed on the importance of offering palliative care early, possibly at the 
time of diagnosis, and ensuring its availability on request throughout the course of the illness. 
Participants also highlighted the need for palliative care at certain other points in the progress 
of patients’ conditions, including the point when active treatment ceases, when a carer needs a 
respite, when there is need for symptom control, when the patient has a symptom that cannot 
be dealt with better elsewhere, and when the patient is dying (though it was acknowledged that 
the end stage of conditions with complex symptomatology was not always easy to pinpoint). 
These findings confirmed the need for a flexible approach to the development of a palliative 
care constituency. 
As for the fourth question, concerning the diagnostic categories in which people should be 
given access to palliative care: apart from cancer, particular concern was expressed for people 
suffering from haematological and renal diseases; neurological disorders such as motor 
neurone disease; respiratory diseases such as cystic fibrosis; Alzheimer’s disease; and cardiac 
conditions.  
When asked to define a palliative care constituency, with particular attention as to how this 
may be limited in a practical sense, participants suggested the use of symptom- or needs-based 
as well as condition-specific considerations. Needs-based considerations include the extent to 
which the condition is life-limiting, the severity of the symptoms, the treatment options 
available, the kinds of support needed, and the choice of the patient and family.  
Defining a conceptual model of palliative care constituencies 
The findings from the focus groups confirmed that palliative care should be available to all 
who need it. They illustrated that palliative care services had focused on people with cancer, 
possibly to the neglect of those suffering from other life-limiting, complex and painful 
conditions. However, they also highlighted the need for a flexible and, possibly, a needs-based 
approach. 
The challenges for the researchers in developing a model of palliative care constituencies were 
to take into account the methodological restrictions of population based research, while 
simulating, if possible, a potential needs-based approach. Using the feedback from the focus 
groups as a starting point, a review of the research literature was undertaken to identify the 10 
conditions that most require palliative care. The 10 conditions that finally emerged within the 
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literature and that confirmed findings from the focus groups were: cancer, heart failure12,55, 
renal failure56, chronic obstructive pulmonary disease55,57, Alzheimer’s disease58-59, liver 
failure60, Parkinson’s disease61-62, motor neurone disease55,63, HIV/AIDS64 and Huntington’s 
disease65. These 10 conditions comprised a proposed minimal palliative care constituency. In 
other words, it was proposed that people diagnosed with any of these 10 conditions should be 
automatically eligible for specialist palliative care services (SPCS). While not all people 
suffering from these conditions may require or choose palliative care, it was also recognised 
that this is a conservative estimate of the people who might require palliative care. It is the 
most restrictive of the three potential needs-based constituencies proposed. Put another way, 
not all people within these 10 groups may require palliative care in the last year of their lives, 
but a large number will, and possibly others will that do not have one of the 10 listed 
conditions. 
A second estimate, the mid-range palliative care constituency, was proposed to include 
people who were hospitalised during the 12-month period before their death, the reason for 
admission matching the underlying cause of death on the death certificate. These additional 
criteria signalled that the patient and doctors had some advance evidence that the patient’s state 
of health was compromised, and that the disease did not arise immediately prior to death. 
While 12 months is an arbitrary period, palliative care services are often accessed during this 
time period. However, the mid-range could be defined variously by changing the time to reflect 
a level or urgency of potential need. 
The third and most comprehensive estimate, the maximal palliative care constituency, 
included all but sudden deaths. It was defined so as to exclude poisoning, injury, or death 
originating during pregnancy, childbirth, the puerperium or the perinatal period. It was 
indicative of inclusive criteria of potential need, where palliative care could be appropriate for 
a wide range of dying people. 
The definitions of the three palliative care constituencies are summarised in Table 1. 
Table 1: Definitions of the minimal, mid-range and maximal palliative care constituencies 
 
Estimate Operational definition Identification of cases 
Minimal Death from 10 causes: cancer, heart failure, renal failure, 
liver failure, chronic obstructive pulmonary disease, 
motor neurone disease, Parkinson’s disease, Huntington’s 
disease, Alzheimer’s disease and HIV/AIDS. 
Mention of any of the 10 causes in Part 
1 of Death Certificate. 
Mid-
range 
Person was admitted to hospital in the last 12 months of 
life for the same condition recorded on the Death 
Certificate.   
Underlying cause of death recorded on 
the Death Certificate matched the 
principal or secondary diagnosis fields 
of the HMDS for admissions in the last 
year of life.  
Maximal Deaths from all causes except: 
• during pregnancy, childbirth or the puerperium (O00-
O99)   
• originating during the perinatal period (P00-P96) 
• resulting from injury, poisoning & certain other 
external causes (S00-T98); or 
• resulting from external causes of morbidity and 
mortality (V01-Y98) 
All deaths except those that mentioned 
the excluded conditions in Part 1 of the 
Death Certificate. 
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Describing the Western Australian palliative care constituencies  
Key points 
1. The minimal palliative care constituency included 50% of the population of people 
who died in Western Australia between 1 July 2000 and 31 December 2002. The 
mid-range palliative care constituency included 56% of this population, and the 
maximal palliative care constituency included 89%. 
2. Slightly more than half (54%) of the minimal constituency died of malignancies, the 
most common remaining conditions being heart failure (19%), renal failure (9%), 
chronic obstructive pulmonary disease (9%), Alzheimer’s disease (4%) and liver 
failure (3%). 
3. Of the people in the minimal constituency, four out of five were aged over 65 years; 
one in 50 was Aboriginal; half were married and a third were widowed; seven out of 
10 lived in a major city; and a third were socioeconomically disadvantaged. 
Objective two was to describe the characteristics of the Western Australian palliative care 
constituencies in terms of their condition, age group, gender, aboriginality, geographical 
remoteness, and level of socioeconomic disadvantage. This chapter uses the data from the 
population-based study to answer the objective: 
• first, by indicating how many people, and thus what proportions of the population, are 
included in the three palliative care constituencies defined in the last chapter, 
• second, by determining the proportions of people with each of the 10 tracer conditions 
included in the minimal palliative care constituency, and 
• last, by describing the proportions of people in each constituency in terms of the 
demographic variables: age, gender, aboriginality, geographical remoteness, and level of 
socioeconomic disadvantage. 
The sizes of the three constituencies 
There were 27,971 deaths from all causes in Western Australia over the study period. Foetal 
deaths (i.e., deaths in utero) and deaths at less than 1 day of age (n = 509) were excluded, 
leaving 27,462 deaths. The underlying cause of death was missing in 580 records (2.1%). 
Exclusion of these 580 records reduced the valid population to 26,882. This population was 
used in all subsequent analyses. 
The minimal palliative care constituency consisted of 13,453 people (50.0% of all deaths), or 
283.2 deaths per 100,000 of the population per year.  
The mid-range palliative care constituency consisted of 14,919 people (55.5% of all deaths) 
or 314.1 deaths per 100,000 of the population per year.  
The maximal palliative care constituency consisted of 24,032 people (89.4% of all deaths), 
or 505.9 deaths per 100,000 of the population per year.  
A diagrammatic representation of the palliative care constituencies model is shown in Figure 2. 
Results 
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Proportions of the population with each condition in the minimal constituency 
The minimal palliative care constituency was defined in terms of the presence of any of 10 
tracer conditions as a cause of death. The percentages of deaths from each of the 10 tracer 
conditions within this constituency is shown in Table 2. Slightly over half of the people in this 
constituency died of a malignant neoplasm. The commonest non-malignant conditions were 
heart failure, renal failure, chronic obstructive pulmonary disease, Alzheimer’s disease and 
liver failure. 
The majority (91.3%) of people in the minimal palliative care constituency died from one 
tracer condition, as shown in Table 3, but small proportions of the population had up to four 
conditions.   
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Table 2: Frequency of 10 tracer conditions, Western Australia deaths from 1 July 2000 to 31 
December 2002 (n=14,709)1 
 
Condition listed as a cause of death in death certificate % 
Neoplasm 54.4 
Heart failure 19.2 
Renal failure 8.9 
Chronic Obstructive Pulmonary Disease  8.7 
Alzheimer’s disease  3.6 
Liver failure  2.9 
Parkinson’s disease 0.1 
Motor neurone disease  0.1 
HIV/AIDS  <0.1 
Huntington’s disease  <0.1 
It was impossible to distinguish between acute liver failure and chronic liver failure due to the 
nature of the ICD-10-AM coding system. Therefore, it is possible that some people who died 
from acute liver failure should have been excluded from the minimal estimate because the 
onset of disease and death was too rapid for them to benefit from specialist palliative care 
services.  
Table 3: Proportions of people with one or more tracer conditions mentioned in Part 1 of the 
Death Certificate in the minimal palliative care constituency from 1 July 2000 to 31 
December 2002 (n=13,453) 
 







Demographic characteristics of people in the three palliative care constituencies 
As shown in Table 4, the people who comprised the palliative care constituencies (minimal, 
mid-range and maximal) tended to be: 
• aged 65 years and older (79% - 82%);  
• non-aboriginal (93% - 94%);  
• married (43% - 49%) or widowed (33 % - 38%);  
• living in the major cities of Western Australian (71% - 72%); and 
• socioeconomically advantaged (52%), with one third being socioeconomically 
disadvantaged.   
                                                 
1Where a person died of more than one tracer condition (see Table 3), all conditions are listed. Consequently, 
in Table 2, N=14,709 (not 13,453, which is the size of the minimal constituency). 
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Table 4:  Demographic characteristics of the Western Australian palliative care 
constituency, July 2000 to December 2002 
 
Variable Minimal 
(n = 13,453) 
%  
Mid-range 
(n = 14,919) 
%  
Maximal 
(n = 24,032) 
% 
Total deaths 
(n = 26,882) 
Age  Missing 1 1 2 3 
  0 to 14 0.3 0.4 0.8 1.3 
  15 to 24 0.3 0.3 0.3 1.5 
  25 to 34 0.7 0.8 0.8 2.3 
  35 to 44 2.0 2.0 2.1 3.1 
  45 to 54 6.0 5.8 5.1 5.6 
  55 to 64 11.9 11.2 9.4 9.2 
  65 to 74 22.5 21.8 18.9 17.8 
  75 to 84 31.7 32.1 31.5 29.8 
  85+ 24.6 25.7 31.2 29.4 
Gender  Missing 1 1 1 1 
  Male 53.4 52.9 50.9 52.3 
Aboriginality  Missing 4.1 4.0 4.2 4.3 
  Aboriginal 2.2 2.4 2.7 3.0 
Marital status  Missing 5.1 5.1 5.8 7.7 
  Divorced 8.3 8.1 7.7 7.8 
  Married 48.8 48.0 43.4 42.3 
  Widowed 33.2 34.1 38.0 36.0 
  Single  4.7 4.7 5.1 6.3 
ARIA+  Missing 0.6 0.6 0.9 1.0 
  Major cities of Australia 71.0 70.6 71.7 71.2 
  Inner regional Australia 13.4 13.4 12.8 12.8 
  Outer regional Australia 10.7 10.8 10.1 10.1 
  Remote Australia 2.7 2.8 2.7 2.8 
  Very remote Australia 1.5 1.6 1.6 1.9 
  Migratory 0.1 0.1 0.1 0.1 
SEIFA –   Missing 0.7 0.8 1.0 1.2 
 Most disadvantaged 17.1 17.2 17.6 17.7 
 More disadvantaged 15.7 15.7 15.8 15.8 
 Average 14.4 14.5 14.1 14.1 
 Less disadvantaged 13.8 13.8 13.5 13.6 
IRSD 
 Least disadvantaged 38.1 38.1 38.0 37.6 
ARIA+:  Area remoteness, based on 2001 Census boundaries.  SEIFA : Socio-economic Indices for Areas, 
based 2001 Census.  IRSD: SEIFA Index of Relative Social Disadvantage.  
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Palliative care and place of death  
Key points 
1. About one third of the minimal constituency died in their usual place of residence, 
about half died in hospital, and the remainder died in hospices, residential aged care 
services and elsewhere. Similar results were found for the mid-range and maximal 
constituencies. 
2. Specialist palliative care services affected where people died. People who did not 
receive specialist palliative care services were much more likely to die in hospital or 
in an aged care facility than people who received specialist palliative care services. 
Objective three was to determine where people in the Western Australian palliative care 
constituencies die, and the effects of receiving palliative care during the last 12 months of life 
on place of death. First, place of death was determined for people in all three constituencies, 
and the proportions of people in the population who died in their usual place of residence, in 
hospitals, hospices, aged care facilities and elsewhere were calculated. Second, patterns of 
SPCS were examined for people in the minimal constituency in terms of whether it was home-
based, hospital-based, both or neither. The place of death of people who did and did not 
receive these various SPCS were determined and odds ratios were calculated.  
 
Place of death for people in the palliative care constituencies 
Table 5 shows the proportions of people who died in their usual place of residence and in a 
place other than their usual place of residence. Table 5 subdivides places other than the usual 
place of residence into hospitals, hospices, residential aged care facilities and other places. 
Approximately one third of people in each constituency died in their usual place of residence, 
about half died in hospital, and the remainder died in hospices, residential aged care services 
and elsewhere.   
 
Table 5: Proportions of people from each of the palliative care constituencies by place of death 









Usual place of residence 
 
32.3 30.0 37.0 
Other than usual place of residence 67.7 70.0 63.0 
     Hospital      51.0      54.5      49.0 
     Hospice      10.7        9.8        6.1 
     Residential aged care facility        3.2        3.1        4.1 
     Other        2.8        2.6        3.8 
Total 100.0 100.0 100.0 
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Effects of receiving palliative care on place of death  
Table 6 shows the odds of dying in a hospital or a residential aged care facility, depending 
upon the SPCS received, for people in the minimal constituency. People who received no 
SPCS were much more likely to die in hospital or in an aged care facility than people who 
received (a) hospital-based SPCS; (b) home-based SPCS; (c) both home- and hospital-based 
SPCS; or (d) any type of SPCS (either hospital, home, or both hospital and home). 
 
Table 6: Odds ratios of dying in hospital and residential aged care facility for people 
who received no SPCS in the minimal constituency from 1 July 2000 to  
31 December 2002 
 
 Odds of dying in hospital Odds of dying in a residential 
aged care facility 
 OR 95% CI OR 95% CI 
No SPCS versus hospital-based SPCS 
 
1.50 1.08 to 2.08 3.57 2.38 to 5.55 
No SPCS versus home-based SPCS 
 
7.69 5.56 to 10.00 14.29 11.11 to 20.00 
No SPCS versus both hospital- and home-
based SPCS 
3.44 2.50 to 4.76 6.67 4.55 to 10.00 
No SPCS versus SPCS (either hospital, 
home or both) 
3.80 3.04 to 4.75 9.56 7.66 to 11.94 
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Specialist palliative care delivery patterns for population subgroups 
Key points 
1. In the minimal and mid-range constituencies, two people in five received specialist 
palliative care services in the last year of life. In the maximal constituency, one in 
four received specialist palliative care services. 
2. Two thirds of the people who died of malignancies received specialist palliative care 
services, but less than one in ten people who died of non-malignant conditions 
received specialist palliative care services. 
3. The non-malignant conditions most likely to receive specialist palliative care 
services were HIV/AIDS (50%), motor neurone disease (35%), Huntington’s disease 
(23%), liver failure (17%), and renal failure (12%). SPCS rates for heart failure 
(9%), chronic obstructive pulmonary disease (7%), Parkinson’s disease (4%) and 
Alzheimer’s disease (3%) were less than 10%. 
4. People were less likely to receive specialist palliative care services if they were aged 
over 84 years, female, Aboriginal, living in outer regional and more remote areas, or 
more socioeconomically disadvantaged. 
Objective four was to study patterns of SPCS delivery during the last 12 months of life, 
comparing use between different socio-demographic groups and between people with different 
causes of death. To answer this objective: 
• Levels of use of home-based SPCS and hospital-based SPCS were determined for people 
in the minimal, mid-range and maximal constituencies.  
• People in the minimal constituency were divided into subgroups, depending upon their 
underlying cause of death, and rates of SPCS use in the last 12 months of life were 
compared across these subgroups. 
• People in all constituencies were divided into subgroups depending on their age, gender, 
aboriginality, geographical remoteness and socio-economic level. Rates of SPCS were 
compared across these subgroups using odds ratios. 
 
Current levels of use of specialist palliative care services  
Table 7 shows the proportions of people in the minimal, mid-range and maximal constituencies 
who received SPCS during the last 12 months of life. In the minimal and mid-range 
constituencies, roughly 40% of the population received some type of SPCS, but in the maximal 
constituency, only 25% received SPCS. The proportions who received home-based, hospital-
based, and both home and hospital SPCS were similar, with home-based being the most 
common in all three constituencies, and hospital-based the least. 
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Table 7:  Proportions of people in each constituency who received each type of SPCS from 




(N = 5 381) 
Mid-range 
(N = 5 968) 
Maximal 
(N = 9 613) 
SPCS 42.7 39.3 25.3 
      Home-based only 15.3 14.0 9.1 
      Hospital-based only 12.5 11.7 7.7 
      Both home & hospital 14.9 13.6 8.5 
No SPCS 57.3 60.7 74.7 
 
Levels of use of specialist palliative care services for people with and without 
malignancies 
Using the minimal palliative care constituency, the proportions of people who received home-
based SPCS, hospital-based SPCS, both and neither were examined, by their condition. Table 8 
shows that the rate of SPCS for people dying of malignancies (67.7%) was much higher than 
the rate of SPCS for people dying of non-malignant conditions (8.2%). 
 
Table 8: Proportions of people in each group who received SPCS in the last year of life from 
1 July 2000 to 31 December 2002 (n = 13,453) 
 
 Malignancy only  
 
(n = 7,399) 
Non-malignancy 
only  
(n = 5,446) 
Malignancy and 
non-malignancy  
(n = 608) 
SPCS 67.7   8.2 48.2 
     Home-based only      23.9        3.1      20.2 
     Hospital only      18.7        3.9      13.2 
     Home-based and hospital combined 
 
     25.1        1.1      14.8 
No SPCS 32.3 91.8 51.8 
Table 9 shows that the rates of SPCS use for each of the non-malignant conditions was 50% or 
less, and that several (heart failure, chronic obstructive pulmonary disease (COPD), 
Alzheimer’s disease, Parkinson’s disease) were less than 10%. 
Levels of use of specialist palliative care services for socio-demographic groups 
Crude odds ratios were calculated to show the likelihood of receiving SPCS for each group.  
These odds ratios were then adjusted for the remaining socio-demographic variables to show 
the likelihood of receiving SPCS independently of these other variables. Tables 10 to 12 show 
the following significant effects: 
• People aged over 84 years were less likely to receive SPCS than the younger age groups.  
• Women were less likely to receive SPCS than men (in the minimal and mid-range 
constituencies). 
• Aboriginal people were less likely to receive SPCS than people who were not Aboriginal.  
• People living in outer regional and more remote areas were less likely to receive SPCS 
than people living in major cities.   
• People who were most socioeconomically disadvantaged were less likely to receive 
SPCS than people who were least disadvantaged. 
Results 
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Table 10: Odds ratios for service coverage in the minimal palliative care constituency 
during the year before death, July 2000 to December 2002 
 
Crude estimates Adjusted estimates Variable 
OR 95% CI OR 95% CI 
Age     
 0 – 14 3.16 1.74 - 5.76 3.48 1.89 – 6.39 
 15 – 24 5.06 2.58 – 9.94 5.69 2.83 – 11.43 
 25 – 34 6.26 4.12 – 9.49 9.64 6.08 – 15.28 
 35 – 44 5.44 4.22 – 7.02 6.18 4.73 – 8.07 
 45 – 54 6.20 5.26 – 7.31 7.07 5.94 – 8.41 
 55 – 64 5.79 5.08 – 6.60 6.33 5.52 – 7.27 
 64 – 74 4.00 3.58 – 4.46 4.20 3.74 – 4.71 
 75 – 84 2.72 2.45 – 3.01 2.72 2.44 – 3.03 
 85 - HIGH Referent category 
Gender     
 Female  0.79 0.74 – 0.85 0.91 0.84 – 0.98 
 Male Referent category 
Aboriginality     
 No  1.88 1.45 – 2.42 2.19 1.64 – 2.94 
 Yes Referent category 
ARIA+     
 Migratory 0.68 0.23 – 2.03 No data 
 Very remote 
Australia 
0.54 0.40 – 0.73 0.53 0.38 – 0.75 
 Remote Australia 0.47 0.37 – 0.60 0.44 0.34 – 0.56 
 Outer regional 
Australia 
0.65 0.58 – 0.73 0.65 0.57 – 0.74 
 Inner regional 
Australia 
0.91 0.82 – 1.00 0.91 0.82 – 1.02 
 Major cities of 
Australia 
Referent category 
SEIFA – IRSD     
 Most disadvantaged 0.83 0.75 – 0.92 0.84 0.75 – 0.93 
 More disadvantaged 0.90 0.82 – 1.00 0.91 0.82 – 1.02 
 Average 0.85 0.77 – 0.95 0.89 0.79 – 1.00 
 Less disadvantaged 0.97 0.87 – 1.08 0.95 0.84 – 1.07 
 Least disadvantaged Referent category 
 Dependent variable  = SPCS from any source (home-based or hospital-based). 
 Aboriginality: ‘yes’ includes people who identified as Aboriginal or Torres Strait Islander 
or both. 
 ARIA+ categories: based on 2001 Census boundaries. 
 IRSD categories: based on 2001 Census. 
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Table 11: Odds ratios for service coverage in the mid-range palliative care constituency 
during the year before death, July 2000 to December 2002 
 
Crude estimates Adjusted estimates Variable 
OR 95% CI OR 95% CI 
Age     
 0 – 14 2.38 1.37 – 4.14 2.59 1.48 – 4.53 
 15 – 24 4.08 2.20 – 7.57 4.90 2.57 – 9.33 
 25 – 34 4.75 3.27 – 6.90 6.98 4.65 – 10.47 
 35 – 44 5.06 3.98 – 6.43 5.71 4.44 – 7.34 
 45 – 54 6.11 5.21 – 7.15 7.05 5.96 – 8.34 
 55 – 64 5.82 5.12 – 6.60 6.36 5.57 – 7.26 
 64 – 74 4.04 3.63 – 4.49 4.24 3.80 – 4.74 
 75 – 84 2.65 2.40 – 2.92 2.66 2.40 – 2.95 
 85 – HIGH Referent category 
Gender     
 Female  0.79 0.74 – 0.84 0.91 0.84 – 0.98 
 Male Referent category 
Aboriginality     
 No  1.97 1.54 – 2.51 2.24 1.70 – 2.96 
 Yes Referent category 
ARIA+     
 Migratory 0.64 0.22 – 1.85 No data 
 Very remote 
Australia 
0.51 0.38 – 0.69 0.51 0.36 – 0.70 
 Remote Australia 0.46 0.37 – 0.58 0.44 0.34 – 0.55 
 Outer regional 
Australia 
0.66 0.59 – 0.74 0.65 0.57 – 0.73 
 Inner regional 
Australia 
0.92 0.83 – 1.01 0.92 0.83 – 1.02 
 Major cities of 
Australia 
Referent category 
SEIFA - IRSD     
 Most disadvantaged 0.84 0.76 – 0.92 0.84 0.76 – 0.94 
 More disadvantaged 0.91 0.82 – 1.00 0.91 0.82 – 1.02 
 Average 0.87 0.79 – 0.96 0.92 0.82 – 1.03 
 Less disadvantaged 0.99 0.90 – 1.10 0.97 0.87 – 1.09 
 Least disadvantaged Referent category 
 Dependent variable  = SPCS from any source (home-based or hospital-based). 
 Aboriginality: ‘yes’ includes people who identified as Aboriginal or Torres Strait Islander 
or both. 
 ARIA+ categories: based on 2001 Census boundaries. 
 IRSD categories: based on 2001 Census. 
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Table 12: Odds ratios for service coverage in the maximal palliative care constituency 
during the year before death, July 2000 to December 2002 
 
Crude estimates Adjusted estimates Variable 
OR 95% CI OR 95% CI 
Age     
 0 – 14 1.17 0.75 – 1.82 1.44 0.91 – 2.28 
 15 – 24 2.80 1.65 – 4.73 3.45 2.00 – 5.92 
 25 – 34 3.58 2.60 – 4.92 5.32 3.79 – 7.47 
 35 – 44 4.02 3.29 – 4.92 4.95 4.01 – 6.11 
 45 – 54 5.72 5.00 – 6.55 6.70 5.82 – 7.73 
 55 – 64 6.07 5.44 – 6.78 6.74 6.00 – 7.56 
 64 – 74 4.45 4.05 – 4.89 4.73 4.28 – 5.22 
 75 – 84 2.74 2.50 – 2.99 2.78 2.53 – 3.04 
 85 - HIGH Referent category 
Gender     
 Female  0.76 0.71 – 0.80 0.95 0.89 – 1.01 
 Male Referent category 
Aboriginality     
 No  2.03 1.63 – 2.54 2.47 1.92 – 3.18 
 Yes Referent category 
ARIA+     
 Migratory 0.74 0.28 – 1.98 No data 
 Very remote 
Australia 
0.59 0.45 – 0.76 0.62 0.46 – 0.83 
 Remote Australia 0.54 0.44 – 0.67 0.50 0.40 – 0.62 
 Outer regional 
Australia 
0.80 0.72 – 0.89 0.79 0.71 – 0.88 
 Inner regional 
Australia 
1.03 0.94 – 1.12 1.03 0.94 – 1.13 
 Major cities of 
Australia 
Referent category 
SEIFA - IRSD     
 Most disadvantaged 0.87 0.80 – 0.95 0.83 0.76 – 0.91 
 More disadvantaged 0.92 0.84 – 1.00 0.88 0.80 – 0.97 
 Average 0.94 0.86 – 1.03 0.92 0.84 – 1.02 
 Less disadvantaged 1.03 0.94 – 1.13 0.98 0.89 – 1.09 
 Least disadvantaged Referent category 
 Dependent variable  = SPCS from any source (home-based or hospital-based). 
 Aboriginality: ‘yes’ includes people who identified as Aboriginal or Torres Strait Islander 
or both. 
 ARIA+ categories: based on 2001 Census boundaries. 
 IRSD categories: based on 2001 Census. 
 
Results 
Who receives specialist palliative care in Western Australia –– and who misses out     25 
Home- and hospital-based specialist palliative care 
Key points 
1. One person in four in the minimal and mid-range constituencies, and one in six in 
the maximal constituency had a hospital admission for specialist palliative care 
services during the last 12 months of life. People spent, on average, between 17 and 
18 days in hospital receiving specialist palliative care services during the last 12 
months of life.  
2. Nine people out of 10 in the minimal and mid-range constituencies, and eight people 
out of 10 in the maximal constituency were admitted to hospital in their last year for 
hospital admissions not involving specialist palliative care services. The average 
days spent in hospital for non-palliative service care was between 34 and 36. 
3. Slightly less than one person in three in the minimal and mid-range constituencies, 
or one in six in the maximal constituency received home-based specialist palliative 
care services in the last 12 months of life. 
4. People who received any type of specialist palliative care services (hospital only, 
home only, or both hospital and home) spent on average 5 days more in hospital but 
6 days less in non-palliative service hospital admissions. 
Objective five was to study the relationships between home-based and hospital SPCS for 
people during the last 12 months of life. To answer this objective, use of SPCS was divided 
into hospital-based SPCS and home-based SPCS, and each of these is considered separately. 
The relationship between SPCS and hospital admissions is then considered. 
 
Hospital-based specialist palliative care services 
Table 13 shows hospital-based SPCS use for each of the three constituencies. One person in 
four (in the minimal and mid-range constituencies) or one in six (in the maximal constituency) 
had a SPCS hospital admission in the last 12 months of life. Across constituencies, the average 
number of admissions was 1.6 and the average number of days spent in hospital receiving 
SPCS was between 17 and 18. This represents an average length of stay of 11.1 days, slightly 
less than the 12.3 days reported by the Australian Institute of Health and Welfare (AIHW)66.  
Nine people out of 10 in the minimal and mid-range constituencies, and eight people out of 10 
in the maximal constituency were admitted to hospital in their last year for non-SPCS hospital 
admissions, and the average non-SPCS days spent in hospital was 34 to 36 days per person. A 
comparison of those who did receive hospital-based SPCS with those who did not, in terms of 
their non-SPCS hospital admissions, showed only one significant difference: in the minimal 
constituency the average length of stay was greater for people who had had no SPCS hospital 
admission (mean difference = 7.4 days, 95% CI 6.1 – 8.7, p < 0.0001). 
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Table 13: Hospital use in the 12 months before death for each palliative care constituency, 
July 2000 to December 2002 
 
 Minimal estimate 
(n = 13,453) 
Mid-range estimate 
(n = 14,919) 
Maximal estimate  
(n = 24,032) 
SPCS hospital admissions 
Proportion of people with at least one 
admission 
27.4% 25.3%  16.2% 
Average number of admissions  1.6 1.6 1.6 
Average number of bed days/person 17.6 17.4 17.2 
Other hospital admissions – total 
Proportion of people with at least one 
admission 
 88.3% 89.4% 79.9% 
Average number of admissions 7.0 6.6 5.6 
Average number of bed days/person 36.0 35.6 33.9 
Other hospital admissions for people who had a SPCS admission (breakdown of total) 
Proportion of people with at least one 
admission  
94.0%  93.9%  93.7% 
Average number of admissions  6.7 6.6 6.6 
Average number of bed days/person  30.8 30.9 31.0 
Other hospital admissions for people who did not have a SPCS admission (breakdown of total) 
Proportion of people with at least one 
admission  
86.2%  87.9% 77.2% 
Average number of admissions  7.1 6.6 5.4 
Average number of bed days/person  38.2 37.3 34.6 
 
Home-based specialist palliative care services 
Use of home-based SPCS is shown in Table 14. Less than one person in three (in the minimal 
and mid-range constituencies) or one in six (in the maximal constituency) received home-based 
SPCS in the last 12 months of life. Fifty-eight percent of these people also received home-
based non-SPCS (e.g., personal care, domestic assistance, respite). People who received no 
home-based SPCS were less likely to receive home-based non-SPCS services (only about one 
in four did so), but received 48.1 more visits (95% CI 41.8 – 54.4 visits, p < 0.001) and 28.4 
hours more home-based, non-specialist palliative care (95% CI 23.9 – 32.8 hours, p < 0.001).    
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Table 14: Use of home-based care the 12 months before death for each palliative care 
constituency estimates, July 2000 to December 2002 
 
 Minimal estimate 
(n = 13,453) 
Mid-range estimate 
(n = 14,919) 
Maximal estimate 
(n = 24,032) 
Home-based SPCS 
Proportion of people using home-based 
SPCS 
30.3% 27.6% 17.7% 
Average visits 46.6 46.4 45.7 
Average client attributable time 
(hours)  
30.8 30.7 30.2 
Other home-based services – total 
Proportion of people using other home- 
based services 
 35.8%  34.7% 28.0% 
Average visits 47.3 50.2 59.5 
Average client attributable time 
(minutes) 
31.0 33.0 39.6 
Other home-based services for people who also received home-based SPCS (breakdown of total) 
Proportion of people using SPCS 58.6% 58.6%  58.4% 
Average visits 23.1 23.3 24.3 
Average client attributable time 
(hours) 
16.6 16.9 17.6 
Other home-based services for people who did not receive home-based SPCS (breakdown of total) 
Proportion of people using SPCS 25.9% 25.5%  21.5%  
Average visits 71.2 73.7 80.0 
Average client attributable time (hours) 45.0 47.2 52.4 
Notes: 
Other home-based services exclude codes PAL and PAL.  Additionally, the service coordination and 
assessment component of providing care has been excluded (code SA). 
Total client attributable time includes both in-home and out of home direct care time. 
 
 
Specialist palliative care services and hospitalisations 
The effects of receiving SPCS on number of hospital admissions and days was examined, 
controlling for the possible confounding effects of age, gender, aboriginality, social 
disadvantage and geographical remoteness. The results showed that people who received SPCS 
from any source spent on average 5.3 days more in hospital (95% CI 3.6 – 7.0 days), but 5.8 
days less in non-SPCS hospital admissions (95% CI 4.2 - 7.4 days less). People who received 
home-based SPCS spent on average 4.4 days less in hospital (95% CI 2.6 – 6.1 days less), but 
3.9 days more in SPCS admissions (95% CI 3.4 – 4.5).  
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A projected costing model for specialist palliative care 
Key points 
1. A costing model was developed for use of hospital- and home-based specialist 
palliative care services by 50%, 75%, 90% and 100% of each palliative care 
constituency. 
2. If 50% of the minimal or mid-range constituencies were to receive hospital-based 
specialist palliative care services, the current Western Australian budget allocation 
for specialist palliative care services would be fully or almost fully spent. 
3. If 50% of the minimal or mid-range constituencies were to receive home-based 
specialist palliative care services, this would cost two to three times as much as is 
currently allocated for the purpose in Western Australia. 
Objective six was to develop a model to estimate the cost of an increased demand on specialist 
palliative care services.  
This analysis estimated the cost of SPCS use under four scenarios, which represented increased 
demand for SPCS: SPCS use by 50%, 75%, 90% or 100% of each palliative care constituency. 
The estimations are based on the assumptions that people who did not receive SPCS during the 
study period would have had similar use patterns (e.g., length of stay) to actual users. 
Costing model for hospital-based specialist palliative care services 
Table 15 shows the effect of increased demand on the use of hospital-based SPCS.  The annual 
cost of providing hospital-based SPCS in the period July 2000 to December 2002 was $9.2 to 
$9.5M, depending on how the palliative care constituency is defined. If half of all people who 
comprised the minimal or mid-range definitions of the palliative care constituency had 
received hospital-based SPCS, this cost would have increased to $16.8 to $18.4M per annum, 
which is approximately equivalent to the $18M directed to palliative care in Western 
Australia67.  
It should be noted that the estimated cost of hospital care has been based on a purchase price of 
$355 per bed day reported by a Western Australian Department of Health official. However, 
anecdotal reports from providers indicate that the actual cost of providing SPCS is 
approximately 30% higher than the purchase price.   
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Table 15: Estimated costs of increased demand on the average per annum use of hospital-
based SPCS in the last year of life 
 
Estimated use of hospital-based SPCS if 
demand increased 
(% palliative care constituency needing SPCS) 
 Actual use of 
hospital- based 
SPCS 
50% 75% 90% 100% 
Minimal estimate (n = 5,381 per annum) 
No. of people with at least 1 admission 1,476 (27.4%) 2,694 4,040 4,848 5,381 
Total number of admissions 2,336 4,263 6,394 7,673 8,526 
Total number of bed days  125,901 47,264  70,884 85,076 94,528 
Estimated cost per annum $9.2M $16.8M $25.2M $30.2M $33.6M 
Mid-range estimate (n = 5,968 per annum) 
No. of people with at least 1 admission 1,510 (25.3%) 2.984 4,476 5,371 5,968 
Total number of admissions 2,376 4,696 7,043 8,452 9,391 
Total number of bed days  26,188 51,755 77,632 93,159 103,510 
Estimated cost per annum $9.3M $18.4M $27.6 $33.1M $36.7M 
Maximal estimate (n = 9,613 per annum) 
No. of people with at least 1 admission 1,588 (16.2%) 4,809 7,213 8,656 9,613 
Total number of admissions 2,436 7,518 11,278 13,533 15,037 
Total number of bed days  26,847 82,861 124,292 149,151 165,724 
Estimated cost per annum $9.5M $29.4M $44.1M $52.9M $58.8M 
 
Costing model for home-based specialist palliative care services 
Table 16 shows the effect of increased demand on the use of home-based SPCS. The annual 
cost of providing home-based SPCS in the period July 2000 to December 2002 was $5.5 to 
$5.6M, depending on how the palliative care constituency was defined. If half of all people 
who comprised the minimal or mid-range definitions of the palliative care constituency had 
received home-based SPCS, this cost would have increased to $9.1 to $15.9M per annum. The 
costing of home-based SPCS is based on a rate of $110 per hour68. Unlike the purchase price 
reported for hospital-based SPCS, the cost for home-based SPCS represents the true cost of 
providing one hour of care.  
                                                 
1Estimations are based on the assumption that people who are not currently receiving SPCS will have similar 
use patterns (e.g., length of stay) to actual users.  Rounding error is present in some cells. 
n = Average per annum count calculated by dividing July 2000 to December 2002 count by 2.5 (years). 
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Table 16: Estimated costs of increased demand on the average per annum use of home-
based SPCS in the last year of life1 
 
Estimated use of home-based SPCS if 
demand increased 
(% palliative care constituency needing SPCS) 
 Actual use of 
home based 
SPCS 
50% 75% 90% 100% 
Minimal estimate (n = 5,381 per annum) 
No. of people using home-based SPCS 1,628 (30.3%) 2,686 4,030 4,836 5,381 
Total visits 75,921 125,282 187,923 225,508 250,564 
Total client attributable time (hours)  50,157 82,767 124,150 148,981 165,535 
Estimated cost per annum $5.5M $9.1M $13.6M 16.4M $18.2M 
Mid-range estimate (n = 5,968 per annum) 
No. of people using home-based SPCS 1,648 (27.6%) 2,985 4,478 5,374 5,968 
Total visits 76,540 138,659 207,989 249,587 277,319 
Total client attributable time (hours)  50,522 91,525 137,288 164,746 183,051 
Estimated cost per annum $5.6M $10.1M $15.1M $18.1M 20.1M 
Maximal estimate (n = 9,613 per annum) 
No. of people using home-based SPCS 1,697 (17.7%) 4,794 7,191 8,629 9,588 
Total visits 77,572 219,130 328,695 394,434 438,260 
Total client attributable time (hours)  51,184 144,588 216,881 260,258 289,175 
Estimated cost per annum $5.6M $15.9M $23.8M $28.6M $31.8M 
 
Costing model for both hospital- and home-based specialist palliative care 
services 
Figure 3 shows the total cost of SPCS (hospital- and home-based combined) for each of the 
constituencies, illustrating actual use, 50% use, 75% use and 90% use, as compared with the 
budget allocation of $18M. It is evident that increasing the accessibility of SPCS to people in 
the various constituencies proposed in this report would far exceed the current budget 
allocation for SPCS. If 50% of the minimal constituency required both hospital- and home-
based SPCS, the budget would be $25.9M and would thus exceed the current budget by over 
40%. 
 
                                                 
1Estimations are based on the assumption that people who are not currently receiving SPCS will have similar 
use patterns (e.g., number of visits) to actual users. Rounding error is present in some cells. 
n = Average per annum count calculated by dividing July 2000 to December 2002 count by 2.5 (years). 
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Section 5 Limitations 
 
 
The main limitations of the present study were as follows: 
1. The constituencies proposed in this study were limited by the data available in the 
population databases, and could not take into account factors such as the severity and 
nature of symptoms, family circumstances or individual preferences for specialist 
palliative care services (SPCS). These constituencies are therefore necessarily at least 
partly condition-based, and are, as such, potential needs-based. 
2. The study may underestimate SPCS use by targeting designated SPCS providers. It has 
been suggested that palliative care is best integrated into general treatment and provided 
by family, friends and healthcare professionals69. However, this level of palliative care is 
not currently possible to quantify in a population database and would not have been 
identified in the present study.  
3. The present study is dependent on the accuracy with which the causes of death are 
specified on death certificates. There is evidence that some conditions, such as 
Alzheimer’s disease70 and chronic obstructive pulmonary disease71-72, may be under-
reported on death certificates. 
4. Families of people who are dying often carry a large financial burden44, and in estimating 
the costs of SPCS, this study did not take account of the costs borne by families. 
5. The period of the study was restricted to only 30 months owing to two factors. One was a 
changeover from ICD-9 to ICD-10 in the records system being used. The other was that 
the reliability of the data from Silver Chain has been established only in recent years. 
Therefore, the forecasting model could not be extended over a longer period of time. 
6. This study was restricted to Western Australia and the results may not be generalisable to 
other countries or other states of Australia. While Western Australia has an 
internationally recognized Data Linkage System that provides unique epidemiological 
study opportunities, other states of Australia will not be able to replicate this study 
easily. In other states and countries there are also usually multiple providers of SPCS, 
whereas in Western Australia, Silver Chain is almost the sole provider of home-based 
palliative care in the metropolitan area. 
7. The present study shows the current patterns of SPCS provision in Western Australia, but 
not the reasons for these patterns. This is recommended as a subject for further research. 
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Section 6 Conclusions and implications 
 
Our study provides unique information on the health care use of people in the last year of their 
lives, that is unprecedented in Australia. There is, to date, no universally accepted normative 
benchmark for defining palliative care needs at the population level. Previous studies have 
been descriptive and dependent on limited methodologies. Our study uses, for the first time, a 
population-based empirical analysis that defines unmet need. By utilising the Western 
Australian Linked Database to present trends in service utilisation, the study has identified 
gaps in the provision of care to terminally ill people in Western Australia.  
Having identified these gaps, we believe that policy makers are now better able to address the 
needs of those most disadvantaged. It is particularly notable that a significant proportion of the 
people who died in the period July 2000 to December 2002 did not receive specialist palliative 
care services. Traditionally, people who die of cancer receive palliative care. It is not 
surprising that this group was well serviced with specialist palliative care, compared to people 
suffering from other life-limiting conditions. Despite this, one third of people who died of 
cancer in this time period did not access specialist palliative care services. Previous 
disadvantage in respect to provision of specialist palliative care services has been noted. This 
population-based study notes the exact extent of this potential need.  
The study demonstrates a strong network of palliative care services once clients are referred to 
any of the specialist palliative care services in Western Australia. Those who receive specialist 
palliative care services in hospital are more likely to receive home-based palliative care 
services and the reverse is also true. Referral to a palliative care service for patients with 
conditions other than cancer is unlikely to occur, with only eight percent of those people with 
conditions recognised to be in a minimal constituency for palliative care receiving specialist 
palliative care services in the period July 2000 to December 2002.  
The study assesses the impact of recent advances in palliative care on the use of the acute 
hospital sector. Increasing palliative care services has the potential to reduce the demand on 
other hospital beds. While it could be argued that reduced demand for acute hospital beds may 
only shift costs to palliative care beds, we argue that patients should have access to the most 
appropriate services for their needs. Costing of hospital beds was beyond the scope of our 
study. However, individual institutions can cost these figures. In addition, people who received 
specialist palliative care services were less likely to die in hospital. Costing of home services 
versus acute hospital care is needed to fully appreciate the importance of these findings. 
To develop our forecasting model, we used a figure based on the total expenditure on palliative 
in Western Australia. If half of the people from the minimal dataset accessed hospital specialist 
palliative care services this would use most, if not all, of the allocated budget for palliative 
care in any one year. This is only hospital-based services. Our study demonstrates that home-
based specialist palliative care is less costly than hospital care. The shift to home-based 
palliative care would not only ease expensive acute hospital care, but also possibly provide 
people more appropriate care at the end of their lives.   
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Section 7 Recommendations 
Recommendations for practice 
The palliative care providers consulted in this study believe that specialist palliative care 
services need to be extended to people with non-malignant, life-limiting conditions. This view 
is also supported by the palliative care literature. Although this view is widely held, the most 
important finding of our study shows that most people dying of conditions other than cancer in 
Western Australia do not receive specialist palliative care. A number of issues need to be 
addressed in order to encourage action: 
• Rather than merely increasing government spending on palliative care, shifting resources 
from acute to palliative care services, while contentious, may be more appropriate. 
• The possible reluctance to refer patients with terminal non-malignant conditions to 
specialist palliative care services, and to treat these people within the services, needs to 
be addressed, possibly with a targeted educational campaign. 
• Further research is needed to compare the end-of-life experiences of people with 
malignant conditions who do and do not receive specialist palliative care, in order to 
explore a needs-based approach to palliative care provision. 
• Public dissemination is needed to draw attention to the broad constituency for palliative 
care so that people with conditions other than cancer are aware of appropriate supportive 
services for people nearing the end of their lives.  
In support of The Palliative Care Service Provision in Australia Planning Guide (2003), we 
have provided a refinement of figures that can be used to project professional staffing needs 
for palliative care services in the future. We therefore recommend that Palliative Care 
Australia consider the following guidelines for a forecasting model: 
• a three-tiered approach to calculating the palliative care constituency (minimal, mid-
range and maximal, although, conceivably the mid-range could be adjusted with advice 
from clinicians and epidemiologists); and 
• use of Western Australian figures, derived from our study, to determine provision of 
services in Western Australia and inform provision of services in other states. 
We have identified groups in the population who are the least well-serviced for specialist 
palliative care, that is, those who are: 
• aged older than 84 years; 
• Aboriginal; 
• live in geographically remote areas; and 
• socio-economically disadvantaged. 
Section 7 Reco endations 
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Recommendations for further research 
We suggest our data be used to support ongoing work that investigates how palliative care can 
be better implemented in aged care, Aboriginal communities and in geographically remote 
areas. While palliative care in aged care accommodation is receiving attention, it is notable that 
the very old (people older than 84) are missing out on palliative care when compared to 
younger people. Further work should be done to investigate the circumstances of these people 
as they approach the end of their lives. One area that has not been highlighted to date is the 
degree to which people who are socioeconomically disadvantaged miss out on receiving 
palliative care. This is an area that needs further investigation.  
The study has raised issues that it could not answer. It has identified that there are factors that 
influence the use, or non-use, of specialist palliative care services. It may be that: 
• people do not know that specialist palliative care services exist;  
• those who do know of palliative care believe that it is inappropriate for their 
circumstances (i.e. they do not believe they are approaching the end of their lives or that 
their symptoms and concerns warrant specialised services); 
• some medical specialists do not refer people to specialist palliative care services;  
• specialist palliative care services limit the number of non-cancer based admissions, or  
• there are other unidentified factors that influence peoples’ non-use of specialist palliative 
care services.   
To address some of these issues the met and unmet needs of terminally ill people in the last 12 
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